XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities    
Net loss $ (8,104,145) $ (7,917,720)
Adjustments to reconcile net loss to cash used in operating activities    
Stock-based compensation expense 106,671 275,688
Issuance of restricted stock 239,505 103,635
Depreciation, amortization and accretion 1,230,671 1,315,063
Issuance of common stock to employee 11,690 0
Derivative (income) (67,989) (817,785)
Changes in operating assets and liabilities:    
(Increase) in accounts receivable (903,708) (849,397)
(Increase) in inventory (305,888) (67,585)
(Increase) in prepaid expenses and other (504,757) (454,595)
Increase in accounts payable and other 252,113 1,124,558
Increase (decrease) in accrued liabilities 746,808 (524,905)
Increase in accrued compensation 203,160 497,586
Increase in interest payable 36,164 0
Increase in deferred revenue 13,990 0
(Decrease) in deferred rent (1,450) (3,337)
Net cash used in operating activities (7,047,165) (7,318,794)
Cash flows used in investing activities    
Deposits 2,888 0
Purchases of property and equipment (12,954) (12,195)
Contingent consideration payment (50,221) 0
Purchase of assets (800,000) 0
Net cash used in investing activities (860,287) (12,195)
Cash flows from financing activities    
Issuance of preferred, common stock and warrants 15,180,000 11,839,995
Issuance costs related to preferred, common stock and warrants (1,479,963) (1,402,831)
Issuance of debt 5,000,000 0
Net cash provided by financing activities 18,700,037 10,437,164
Net change in cash, cash equivalents and restricted cash 10,792,585 3,106,175
Cash, cash equivalents and restricted cash at beginning of period 7,112,527 877,542
Cash, cash equivalents and restricted cash at end of period 17,905,112 3,983,717
Fair value of warrants issued to investors and underwriters 1,888,652 0
Issuance of preferred stock related to purchase of asset 519,600 0
Contingent consideration 8,833,219 0
Warrants issued to investors and underwriters (see Note 6) 0 4,117,997
Revenue share payment to Jazz included in accounts payable 0 7,385
Earn-out payment to Nuelle Shareholders 0 250,000
Fixed assets included in accounts payable $ 0 $ 62,512